[go: up one dir, main page]

Gaynor, 2016 - Google Patents

Re: Generally Recognized as Safe (GRAS) Determination for GLA Safflower Oil (SONOVA®) in Conventional and Medical Foods Dear Dr. Gaynor: Arcadia …

Gaynor, 2016

View PDF
Document ID
1395974472384028368
Author
Gaynor P
Publication year

External Links

Snippet

On June 22, 2015, the US food additive regulations were amended to allow meal from GLA safflower grain to be used in cattle and poultry feed. Currently, Arcadia has pending at the FDA a food additive petition for use of SONOVA 400 GLA Safflower Oil in dog food (FAP …
Continue reading at www.fda.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OF FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL

Similar Documents

Publication Publication Date Title
Shahidi et al. Omega-3 polyunsaturated fatty acids and their health benefits
US10342773B2 (en) Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
Martins et al. The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder–a review
Krauss-Etschmann et al. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-β levels after fish oil supplementation of pregnant women
DE69935995T2 (en) POLYUNGATURATED FATTY ACIDS NUTRITIONAL SUPPLEMENT
Martemucci et al. Fat content, energy value and fatty acid profile of donkey milk during lactation and implications for human nutrition
CN101019853B (en) Composition containing dihomo-γ-linolenic acid (DGLA) as an active ingredient
EP1991217A2 (en) Stearidonic acid for improving cardiovascular health
Rezapour-Firouzi et al. Erythrocyte membrane fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils
Rezapour-Firouzi et al. Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients
Fallah et al. Bee propolis, bee bread, and royal jelly: proximate analysis, fatty acid composition, nutritional quality, and anti-amylase activity
Kawabata et al. Influences of stearidonic acid-enriched soybean oil on the blood and organ biochemical parameters in rats
Gaynor Re: Generally Recognized as Safe (GRAS) Determination for GLA Safflower Oil (SONOVA®) in Conventional and Medical Foods Dear Dr. Gaynor: Arcadia Biosciences, Inc. has developed and intends to market gamma linolenic acid (GLA) safflower oil as conventional and medical food. This letter and attachments
Guilliams Fatty Acids: Essential… Therapeutic
Bégin et al. What Is the link between docosahexaenoic acid, cognitive impairment, and Alzheimer’s disease in the elderly?
JP2006306813A (en) Mast cell increase inhibitor
JP6203320B2 (en) Oral treatment or prevention agent for skin diseases
WO2024106446A1 (en) Composition for relieving or preventing symptoms of allergic rhinitis or allergic conjunctivitis
JP6462790B2 (en) Oral treatment or prevention agent for skin diseases
Valenzuela et al. nutrients MDPI
Kamuhu et al. Effect of Peanut Consumption on Nutritional Status Indices of HIV Infected Adults in Nyeri County, Kenya
JP6214474B2 (en) Oral treatment or prevention agent for skin diseases
Frøyland et al. Evaluation of negative and positive health effects of n-3 fatty acids as constituents of food supplements and fortified Foods. Opinion of the Steering Committee of the Norwegian Scientific Committee for Food Safety
Forchielli et al. ω-3 Fatty Acids: Impact on Cognitive Development and Inflammation
Target NUTRITION Assessment–approval Report APPLICATION A1041–FOOD DERIVED FROM STEARIDONIC ACID SOYBEAN LINE MON87769